Former Executive Vice President, Chief General Counsel and Corporate Secretary · Sarepta Therapeutics, Inc. (SRPT)

Ryan Brown

A named executive officer of Sarepta Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,611,129

Salary $589,269Stock awards $772,020

FY2023: $3,578,331

4th of 6 named executive officers at Sarepta Therapeutics by FY2024 total.

6 named officers on file for Sarepta Therapeutics, FY2024

Ryan Brown’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • SRPT’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sarepta Therapeutics’s whole pay program stands against its peers

  • Sarepta Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SRPT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2025 (DEF 14A).

Free

Get Ryan Brown’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ryan Brown compensation by year

Sarepta Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Sarepta Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024
Salary$473,550$507,968$550,249$589,269
Bonus———$0
Stock awards$1,306,650$643,360$701,955$772,020
Option awards$2,959,290$2,263,099$1,988,909$845,250
Non-equity incentive$260,820$300,639$321,368$387,725
Pension and deferred compensation———$0
All other$103,980$14,753$15,850$16,864
Total$5,104,290$3,729,818$3,578,331$2,611,129

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sarepta Therapeutics, Inc. DEF 14A filed April 24, 2025, accession 0000950170-25-058003, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Sarepta Therapeutics, Inc. filed document, accession 0000950170-25-058003. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2025.

$5.1M
$3.7M
$3.6M
$2.6M
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU17,500$2,127,825—
PSU7,500$911,925—
RSU6,000$729,540—
RSU5,500$668,745—
RSU4,000$486,360—
RSU3,750$455,963—
RSU3,375$410,366—
PSU1,375$167,186—
Option12,500—$128.67
Option15,179—$155.99
Option3,747—$87.11
Option14,992—$80.42

Per the Outstanding Equity Awards at Fiscal Year-End table in Sarepta Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Sarepta Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Ian EstepanPresident, Chief Operating Officer$2,752,522
Louise Rodino-KlapacPresident, Research and Development and Technical Operations$2,737,283
Dallan MurrayFormer Executive Vice President, Chief Customer Officer$2,666,323
Ryan Brown · this pageFormer Executive Vice President, Chief General Counsel and Corporate Secretary$2,611,129
Bilal ArifExecutive Vice President, Chief Technical Operations Officer$2,539,138
Douglas IngramChief Executive Officer$1,978,086

The full Sarepta Therapeutics compensation record

free company brief

This page is one person within Sarepta Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Sarepta Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sarepta Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ryan Brown's compensation dossier · One-time report. No refunds.